{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:33:50Z","timestamp":1773308030349,"version":"3.50.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1990,7,1]],"date-time":"1990-07-01T00:00:00Z","timestamp":646790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>During routine screening for anti-nuclear antibodies, using rat liver tissue as substrate, a reactivity against bile duct epithelium was observed in sera from carcinoid tumour patients given human leucocyte-derived IFN-a (HuLe IFN-a). In a retrospective study, initiated by this observation, the development of serum antibodies to bile duct epithelium was observed in nine out of 12 patients with carcinoid tumours and in three out of 14 patients with hairy-cell leukaemia during their treatment with HuLe IFN-\u03b1. However, no bile duct reactivity was observed in sera from carcinoid or hairy-cell leukaemia in patients given recombinant IFN-\u03b1. When analysing the reactivity of positive sera against a panel of rat and human tissues, a uniform reactivity was observed against simple epithelial cells lining the gastrointestinal tract, pancreatic secretory ducts, fallopian tube, kidney tubuli. mesothelium and also against carcinoid tumour cells. The mechanisms promoting autoreactivity against this simple epithelial cell auloantigen is so far unknown. The cytoplasmic as well as the restricted staining pattern of simple epithelial cells may indicate autoreactivity against certain cytoskelelal intermediate filaments, such as cytokeratin19, 18 and8, known to be exclusively present in simple epithelial cells and tumours derived from them.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1990.tb05293.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T23:03:49Z","timestamp":1280185429000},"page":"72-75","source":"Crossref","is-referenced-by-count":19,"title":["Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-\u03b1)"],"prefix":"10.1093","volume":"81","author":[{"given":"A","family":"KARLSSON-PARRA","sequence":"first","affiliation":[{"name":"Department of Clinical Bacteriology, University of Uppsala, Uppsala. Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"BURMAN","sequence":"additional","affiliation":[{"name":"Department of Inlernal Medicine, University of Uppsala, Uppsala. Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"HAGBERG","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, University of Uppsala, Uppsala. Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"\u00d6BERG","sequence":"additional","affiliation":[{"name":"Ludwig Institute for Cancer Research, University of Uppsala, Uppsala. Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"ALM","sequence":"additional","affiliation":[{"name":"Interferon Laboratory, University of Uppsala, Uppsala. Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"KLARESKOG","sequence":"additional","affiliation":[{"name":"Department of Medical and Physiological Chemistry, University of Uppsala, Uppsala. Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F A","family":"KARLSSON","sequence":"additional","affiliation":[{"name":"Department of Inlernal Medicine, University of Uppsala, Uppsala. Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011713330818400_b1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198806163182401","article-title":"Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N","volume":"318","author":"Atkins","year":"1988","journal-title":"Engl. J. Med"},{"key":"2022011713330818400_b2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1182\/blood.V67.2.458.458","article-title":"Human recombinant alpha-2C enhances the expression of class II HLA antigens on hairy cells","volume":"67","author":"Baldini","year":"1986","journal-title":"Blood."},{"key":"2022011713330818400_b3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0140-6736(85)90203-X","article-title":"Autoimmune thyroid disease in interferon treated patients","volume":"ii","author":"Birman","year":"1985","journal-title":"Lancet"},{"key":"2022011713330818400_b4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1210\/jcem-63-5-1086","article-title":"Thyroid auloimmunity in patients on long term therapy with leukocyte-derived inlerferon","volume":"63","author":"Burman","year":"1986","journal-title":"J. clin. Endocrinol. Metab."},{"key":"2022011713330818400_b5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1099\/0022-1317-39-3-541","article-title":"Large-scale production of human leukocyte interferon contains 108 units per ml","volume":"39","author":"C'Antell","year":"1978","journal-title":"J. gen. Virol."},{"key":"2022011713330818400_b6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0277-5379(88)90219-2","article-title":"An autoimmune aetiology for hypo-thyrodism following interferon therapy for breast cancer","volume":"8","author":"Fentiman","year":"1988","journal-title":"Eur. J. Cancer clin. Oncol."},{"key":"2022011713330818400_b7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0260-4639(22)00185-2","article-title":"Immunological and therapeutic effects of interferon trcatmenl of cancer patients","volume":"4","author":"Golub","year":"1984","journal-title":"Clin. Immunol. Allergy."},{"key":"2022011713330818400_b8","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/nar\/12.9.3727","article-title":"Differential expression of human inlerferon genes","volume":"12","author":"Hiscott","year":"1984","journal-title":"Nucleic Acids Res."},{"key":"2022011713330818400_b9","article-title":"Thyroid auloimmunity induced by interferon therapy","volume-title":"Frontiers in Hormone Research","author":"Kahlsson","year":"1990"},{"key":"2022011713330818400_b10","first-page":"429","article-title":"Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract","volume":"52","author":"Miettinen","year":"1985","journal-title":"Lab. Invest."},{"key":"2022011713330818400_b11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(82)90400-7","article-title":"The catalog of human cytokcratins: Patterns of expression in normal epithelia. tumors and cultured cells","volume":"31","author":"Moll","year":"1982","journal-title":"Cell."},{"key":"2022011713330818400_b12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198307213090301","article-title":"Effects of leukocyte inlerleron on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome","volume":"309","author":"\u00d6Berg","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"2022011713330818400_b13","first-page":"1297","article-title":"Treatment of malignant endocrine tumors with human leucocyte interferon. Long-term results","volume":"70","author":"\u00d6Berg","year":"1986","journal-title":"Cancer Treat. Rep."},{"key":"2022011713330818400_b14","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1073\/pnas.84.10.3249","article-title":"Cytoskelelal association of human alpha-interferon-receptors complexes in inter-feron-sensitive and -resistant lymphohlasloid cells","volume":"84","author":"Pfeffer","year":"1987","journal-title":"Prac. natl Acad. Sci. USA."},{"key":"2022011713330818400_b15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198401053100104","article-title":"Alpha interferon for induction of remission in hairy-cell leukemia","volume":"310","author":"Quesada","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"2022011713330818400_b16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/blood.V65.3.644.644","article-title":"Treatment of hairy cell leukemia with recombinant alpha-2 interferon","volume":"65","author":"Ratain","year":"1985","journal-title":"Blood."},{"key":"2022011713330818400_b17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/eji.1830160410","article-title":"Antigen presenting by human monocytes: effects of modifying major histocompatibility complex antigen expression and interleukin I production by using recombinant interferons and corticosteroids","volume":"16","author":"Rhodes","year":"1986","journal-title":"Eur. J. Immunol."},{"key":"2022011713330818400_b18","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4049\/jimmunol.120.6.1849","article-title":"Spontaneous cell-mediated cytotoxicity in humans: role of inlerferon and immuno-globulins","volume":"120","author":"Trinchieri","year":"1978","journal-title":"J. Immunol."},{"key":"2022011713330818400_b19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/jir.1982.2.253","article-title":"Human leukocyte-derived alpha-interferons: purification and aminolerminal amino-acid sequence of two components","volume":"2","author":"Zoon","year":"1982","journal-title":"J. Inlerleron Res."}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1990.tb05293.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/81\/1\/72\/42217658\/j.1365-2249.1990.tb05293.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/81\/1\/72\/42217658\/j.1365-2249.1990.tb05293.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T11:27:13Z","timestamp":1740310033000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/81\/1\/72\/6488711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,7]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb05293.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1990,7]]},"published":{"date-parts":[[1990,7]]}}}